An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma

Journal of Clinical Microbiology

Volumn 34, Issue 12, 1996, Pages 3196-3202

  Kern, David ^a   Collins, Mark ^a   Fultz, Tim ^a   Detmer, Jill ^a   Hamren, Sarah ^a   Peterkin, Joanna J ^b   Sheridan, Pat ^a   Urdea, Mickey ^a   White, Roseann ^a   Yeghiazarian, Torange ^a   Todd, John ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b AGOURON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NELFINAVIR; PROTEINASE INHIBITOR; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DNA DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OLIGONUCLEOTIDE PROBE; PLASMA; PRIORITY JOURNAL; VIRUS DETECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 10544252269     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.12.3196-3202.1996     Document Type: Article

References (33)

1. Aoki-Sei, S., R. Yarchoan, S. Kageyama, D. T. Hoekzema, J. M. Pluda, K. M. Wyvill, S. Broder, and H. Mitsuya. 1992. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction. AIDS Res. Hum. Retroviruses 8:1263-1270.
2. Biron, F., F. Lucht, D. Peyramond, A. Fresard, T. Vallet, F. Nugier, J. Grange, S. Mailey, F. Hamedi-Sangsaru, and J. Vila. 1995. Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1-infected individuals. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10:36-40.
3. Cao, Y., D. D. Ho, J. Todd, R. Kokka, M. Urdea, J. D. Lifson, M. J. Piatak, S. Chen, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Clinical evaluation of branched DNA (bDNA) signal amplification for quantifying HIV-1 in human plasma. AIDS Res. Hum. Retroviruses 11:353-361.
4. Collins, M. L., C. Zayati, J. J. Detmer, B. Daly, J. A. Kolberg, T. A. Cha, B. D. Irvine, J. Tucker, and M. S. Urdea. 1995. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal. Biochem. 226:120-129.
5. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67:1772-1777.
6. Danner, S. A., A. Carr, J. M. Leonard, L. M. Lehman, F. Gudiol, J. Gonzales, A. Raventos, R. Rubio, E. Bouza, V. Pintado, A. G. Aguado, J. G. De Lomas, R. Delgado, J. C. C. Borleffs, A. Hsu, J. M. Valdes, C. A. B. Boucher, and D. A. Cooper, for the European-Australian Collaborative Ritonavir Study Group. 1995. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. N. Engl. J. Med. 23:1528-1533.
7. Dewar, R. L., H. C. Highbarger, M. D. Sarmiento, J. A. Todd, M. B. Vasudevachari, R. J. Davey, J. A. Kovacs, N. P. Salzman, H. C. Lane, and M. S. Urdea. 1994. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect. Dis. 170:1172-1179.
8. Eastman, P. S., M. Urdea, D. Besemer, M. Stempien, and J. Kolberg. 1995. Comparison of selective polymerase chain reaction primers and differential probe hybridization of polymerase chain reaction products for determination of relative amounts of codon 215 mutant and wild-type HIV-1 populations. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 9:264-273.
9. Franklin, G. 1976. Theory and application of the linear model, p. 606-648. Wadsworth Publishing Co., Belmont, Calif.
10. Henderson, J. T., A. S. Benight, and S. Hanlon. 1992. A semi-micromethod for the determination of the extinction coefficients of duplex and single-stranded DNA. Anal. Biochem. 201:17-29.
11. Henrard, D. R., J. F. Philips, L. R. Muenez, W. A. Blattner, D. Wiesner, E. Eyster, and J. J. Goedert. 1995. Natural history of HIV-1 cell-free viremia. JAMA 274:554-558.
12. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
13. Ho, D. D., A. S. Perelson, and G. M. Shaw. 1995. HIV results in the frame - reply: Nature (London) 375:198.
14. Hogervorst, E., S. Jurriaans, F. de Wolf, A. van Wijk, A. Wiersma, M. Valk, M. Roos, B. van Gemen, R. Coutinho, F. Miedema, and J. Goudsmit. 1995. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J. Infect. Dis. 171:811-821.
15. Holodniy, M., L. Mole, M. Winters, and T. C. Merigan. 1994. Diurnal and short-term stability of HIV virus load as measured by gene amplification. J. Acquired Immune Defic. Syndr. 7:363-368.
16. Kabat, W., T. Yeghiazarian, J. Wilber, Y. Zhao, and R. Yogev. 1995. Quantification of human immunodeficiency virus type 1 (HIV-1) RNA levels in pediatric population using a modified branched DNA signal amplification method, abstr. 1161, p. 233. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
17. Lin, H. J., L. E. Myers, B. Yen-Lieberman, F. B. Hollinger, D. Henrard, C. J. Hooper, R. Kokka, S. Kwok, S. Rasheed, M. Vahey, M. A. Winters, L. J. McQuay, P. L. Nara, P. Reichelderfer, R. W. Coombs, and J. B. Jackson. 1994. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J. Infect. Dis. 170:553-562.
18. Loveday, C., and A. Hill. 1995. Prediction of progression to AIDS with serum HIV-1 RNA and CD4 count. Lancet 345:790-791.
19. Markowitz, M., M. Saag, W. G. Powderly, A. M. Hurley, A. Hsu, J. M. Valdes, D. Henry, F. Sattler, A. La Marca, J. M. Leonard, and D. D. Ho. 1995. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N. Engl. J. Med. 23:1534-1539.
20. Mellors, J. W., L. A. Kingsley, C. R. J. Rinaldo, J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
21. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
22. Pachl, C., J. A. Todd, D. G. Kern, P. J. Sheridan, S.-F. Fong, M. Stempien, B. Hoo, D. Besemer, T. Yeghiazarian, B. Irvine, J. Kolberg, R. Kokka, P. Neuwald, and M. S. Urdea. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA (bDNA) signal amplification assay. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8:446-454.
23. Piatak, M. J., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
24. Running, J. A., and M. S. Urdea. 1990. A procedure for productive coupling of synthetic oligonucleotides to polystyrene microtiter wells for hybridization capture. BioTechniques 8:276-277.
25. Sánchez-Pescador, R., M. D. Power, P. J. Barr, K. S. Steimer, M. M. Stempien, S. L. Brown-Shimer, W. W. Gee, A. Renard, A. Randolph, J. A. Levy, D. Dina, and P. A. Luciw. 1985. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227:484-492.
26. Semple, M., C. Loveday, I. Weller, and R. Tedder. 1991. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J. Med. Virol. 35:38-45.
27. Todd, J., C. Pachl, R. White, T. Yeghiazarian, P. Johnson, B. Taylor, M. Holodniy, D. Kern, S. Hamren, D. Chernoff, and M. Urdea. 1995. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10:S35-S44.
28. Todd, J., T. Yeghiazarian, B. Hoo, J. Detmer, J. Kolberg, R. White, J. Wilber, and M. Urdea. 1994. Quantitation of human immunodeficiency virus plasma RNA by branched DNA and reverse transcription coupled polymerase chain reaction assay methods: a critical evaluation of accuracy and reproducibility. Serodiagn. Immunother. Infect. Dis. 6:1-7.
29. Urdea, M. S., T. Horn, T. Fultz, M. Anderson, J. Running, S. Hamren, D. Ahle, and C.-A. Chang. 1991. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Res. Symp. Ser. 24:197-200.
30. Urdea, M. S., B. D. Warner, J. A. Running, M. Stempien, J. Clyne, and T. Horn. 1988. A comparison of non-radioisotopic hybridization assay methods using fluorescent, chemiluminescent and enzyme labeled synthetic oligodeoxyribonucleotide probes. Nucleic Acids Res. 16:4937-4956.
31. Warshaw, M. M., and I. Tinoco, Jr. 1966. Optical properties of sixteen dinucleoside phosphates. J. Mol. Biol. 20:29-38.
32. Webb, M. R. 1992. A continuous spectrophotometric assay for inorganic phosphate and for measuring phosphate release kinetics in biological systems. Proc. Natl. Acad. Sci. USA 89:4884-4887.
33. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeliciency virus type 1 infection. Nature (London) 373:117-126.